Picture of Xspray Pharma publ AB logo

XSPRAY Xspray Pharma publ AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Xspray Resolves On Rights Issue Of About SEK 135 Mln, Raises Loan Of SEK 100 Mln

Nov 6 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK 135
MILLION AND RAISES A LOAN OF SEK 100 MILLION
    * SUBSCRIPTION PRICE OF SEK 40 PER SHARE CORRESPONDS TO A
DISCOUNT
OF APPROXIMATELY 27 PERCENT COMPARED TO THEORETICAL PRICE
    * SUBSCRIPTION PERIOD IN RIGHTS ISSUE IS EXPECTED TO RUN
FROM 15
NOVEMBER 2024 UP TO AND INCLUDING 29 NOVEMBER 2024.
    * LOAN IS UNSECURED AND AMOUNTS TO SEK 100 MILLION IN TOTAL
WITH A
TERM OF 12 MONTHS FROM 6 NOVEMBER 2024
    * UPON RAISING OF LOAN, 1,150,000 WARRANTS WILL BE ISSUED TO
LENDERS, FREE OF CHARGE
    * LOAN INCLUDES AN ARRANGEMENT FEE OF 4 PERCENT AND ACCRUES
INTEREST AT STIBOR 3M (HOWEVER MINIMUM 3 PERCENT) PLUS AN
INTEREST MARGIN OF 8 PERCENT

Source text:  ID:nMFN1qRGRG 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xspray Pharma publ AB

See all news